Innovations in Immune-Mediated Skin Conditions: Focus on Alopecia Areata
Pricing: Free for Members and Non-Members
This activity is supported by an unrestricted educational grant from Pfizer, Inc.
Course Description
During this session, presenters will provide an overview of the disease burden of alopecia areata, discuss health care costs and utilization, highlight the patient-specific factors that must be considered when making treatment decisions for a diverse population, and explore the FDA-approved and pipeline pharmacologic treatment options for alopecia areata.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
1. Describe the disease burden of moderate-to-severe alopecia areata on clinical and patient-reported outcomes.
2. Differentiate new and emerging targeted therapies for alopecia areata based on mechanisms of action, efficacy and safety data, and indications.
3. Discuss approaches to managing alopecia areata among a diverse patient population.
4. Identify strategies to manage health care utilization and costs related to alopecia areata.
Faculty
Loren Krueger, MD, FAAD
Assistant Professor, Dermatology
Vice Chair, Diversity, Equity, and Inclusion
Emory University School of Medicine
Steven Kheloussi, PharmD, MBA
Manager, Clinical Pharmacy
Highmark, Inc.
Moderator
Lynn Deguzman, PharmD, BGCP
Clinical Pharmacy Services Director, National Pharmacy
Kaiser Permanente
Financial Relationship Disclosures
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Steve Kheloussi Faculty | Disclosed no relevant financial relationships. |
Loren Krueger Faculty | Disclosed no relevant financial relationships. |
Alan Chuang Reviewer | Disclosed no relevant financial relationships. |
Jennifer Evans Planner | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-22-055-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.0
Release Date: January 23, 2023 • Expiration Date: June 30, 2024
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.00 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.00 Certificate of Completion
Price
Required Hardware/software
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities